Gammagard Liquid 10% regulatory update

Baxter submitted an sBLA to FDA for Gammagard Liquid 10% to treat multifocal motor neuropathy (MMN). The IgG antibodies plasma-based therapy is already approved in the U.S. as replacement therapy for ...